DocGo

DocGo, Inc. engages in the provision of mobile health services. It operates through the following segments: Transportation Services and Mobile Health Solutions. The Transportation Services segment offers on-demand medical mobility solutions which are marketed under the Ambulnz brand. The Mobile Health Solutions segment includes on-site evaluations, diagnostics, triage, treatment, and medicine administration. The company was founded in 2015 by Stanley Vashovsky and is headquartered in New York, NY.

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

DocGo reports stellar 2022 performance and outlines growth strategies

DocGo's strong financial performance in 2022, coupled with robust guidance for 2023 and strategic operational initiatives, positions the company for continued growth and profitability.
While challenges like managing PHE impacts and transitioning to leased hour contracts exist, DocGo's proactive approach and operational strengths provide a solid foundation for addressing these hurdles.
With a focus on optimizing operations, pursuing growth opportunities, and leveraging its financial resources effectively, DocGo is poised to capitalize on market opportunities and deliver value to stakeholders.

DocGo reports Q1 revenue growth amidst margin challenges and future opportunities

DocGo's Q1 2023 performance showcased revenue growth and margin challenges, with a focus on improving margins through normalization initiatives.
Strengths include strong revenue guidance, significant contract opportunities, and partnerships driving backlog growth and revenue diversification.
Challenges stem from replacing high-margin COVID revenue, startup costs impacting margins, and negative cash flow in Q1 2023.
Opportunities lie in future revenue growth from new contracts, RPM services, public-private partnerships, and potential contract wins from upcoming RFPs.

DocGo (DCGO) reports stellar Q2 results, raises full-year guidance

DocGo's Q2 2023 showcased exceptional financial performance, with revenue and EBITDA growth exceeding expectations, underpinned by strong operational metrics and strategic decisions.
While facing challenges in backlog conversion and margin improvements, the company's focus on scalability, employee satisfaction, and market expansion positions it well for future growth.
Opportunities in new geographies, Remote Patient Monitoring integration, and transportation segment enhancements provide avenues for sustained revenue growth and operational excellence.

DocGo reports record Q3 revenue, eyes growth in commercial sector

DocGo's Q3 performance reflects strong revenue growth and improved EBITDA margins, driven by the success of Mobile Health and Transportation Services. While facing challenges with working capital and payment delays, the company is focused on catching up by year-end.
The company's strengths in contract performance, revenue guidance increase, and backlog diversification position it well for future growth. DocGo's strategic focus on commercial business expansion and customer experience enhancement aligns with its growth objectives.

DocGo reports record Q4 earnings, eyes growth in healthcare

DocGo delivered exceptional financial results in Q4 2023, showcasing robust revenue growth and profitability, driven by operational excellence and strategic investments.
While facing margin and cost challenges, the company's focus on growth, value-based care agreements, and revenue diversification positions it well for future success and market expansion.
With a strong cash position, revised revenue guidance, and proactive pursuit of new partnerships, DocGo is poised to capitalize on growth opportunities and navigate challenges effectively.
The company's commitment to transforming healthcare delivery and gratitude towards its staff underscore a resilient corporate culture and a dedication to driving positive impact in the industry.

DocGo reports robust Q1 earnings, eyes growth through unique care model

DocGo's Q1 2024 performance was strong, marked by revenue growth, improved margins, and profitability.
While facing challenges like revenue fluctuations and working capital pressures, the company is well-positioned for growth.
Opportunities lie in becoming a primary care provider, monetization strategies, and market differentiation through quality care.
Overall, DocGo's financial stability, growth plans, and unique service offerings position them for future success in the healthcare sector.

DocGo excels in Q2 2024, sets sights on clinical innovation

DocGo's Q2 2024 performance reflects financial strength and strategic advancements in clinical expertise and service expansion.
While facing challenges in meeting ambitious care gap closure targets, the company is well-positioned for growth.
Leveraging opportunities in mobile healthcare services and clinical program development can drive future success for DocGo.

DocGo reports robust Q3 earnings, eyes growth in migrant-related work

DocGo's Q3 2024 earnings call showcased strong financial performance, operational efficiency, and positive outlook for future revenue and cash flow.
While challenges such as revenue balancing and margin expectations were noted, opportunities for growth through migrant-related work and care programs were highlighted.
Overall, DocGo's performance and strategic direction position the company well for continued success and expansion in the healthcare sector.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

DocGo, Inc. engages in the provision of mobile health services. It operates through the following segments: Transportation Services, Mobile Health Solutions, and Corporate. The Transportation Services segment offers on-demand medical mobility solutions which are marketed under the Ambulnz brand. The Mobile Health Solutions segment includes on-site evaluations, diagnostics, triage, treatment, and medicine administration. The Corporate segment consists of information technology expenses. The company was founded in 2015 by Stanley Vashovsky and is headquartered in New York, NY.

NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq:DCGO), a leading provider of last-mile mobile health services, announced today the launch of its partnership with EmblemHealth, one of the nation's largest not-for-profit health insurers, serving more than three million people in New York City and the tristate area. DocGo will work closely with EmblemHealth to bring timely in-home services to New York and Connecticut patients after hospitalization to close preventive health care gaps. Using a value-.

DocGo and EmblemHealth Launch Partnership to Bring In-Home Care to Patients

DocGo Inc. (NASDAQ:DCGO ) Q2 2023 Earnings Conference Call August 7, 2023 5:00 PM ET Corporate Participants Mike Cole - Director-Investor Relations Anthony Capone - Chief Executive Officer Lee Bienstock - President and Chief Operating Officer Norman Rosenberg - Chief Financial Officer Conference Call Participants Richard Close - Canaccord Genuity Sarah James - Cantor Fitzgerald Matt Shea - Needham & Co Mike Latimore - Northland Capital Markets David Grossman - Stifel Kieran Ryan - Deutsche Bank Operator Good afternoon, and welcome to the DocGo Second Quarter 2023 Earnings Conference Call. At this time all participants are in listen-only mode.

DocGo Inc. (DCGO) Q2 2023 Earnings Call Transcript

DocGo Inc. (DCGO) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of $0.03. This compares to earnings of $0.07 per share a year ago.

DocGo Inc. (DCGO) Reports Q2 Loss, Tops Revenue Estimates

NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO), a leading provider of last-mile mobile health services today announced financial and operating results for the quarter ended June 30, 2023. Q2 2023 Financial Highlights Total revenue for the second quarter of 2023 was $125.5 million, up from $113.0 million in the first quarter of 2023 and $109.5 million in the second quarter of 2022. Mass COVID-testing revenues during each of the first two quarters of 2023 were less than $1.0 million, compar.

DocGo Announces Record Second Quarter 2023 Results

Apple

Amgen

Ardelyx

Celsius Holdings

Coinbase

Cisco Systems

Chevron

Diamond Offshore Drilling Inc

New Oriental Education & Technology Group

e.l.f. Beauty

Enphase Energy

Evolution Petroleum

Fluence Energy

FTC Solar

Genius Sports

GSX Techedu Inc.

Immunocore Holdings

Intel

Inter & Co Inc

JPMorgan Chase & Co

Coca-Cola

MoonLake Immunotherapeutics

Microsoft

Noble Corp PLC

Two new Breakout Stocks for Week 31 curated by the MDA model for 10% short-term upside and additional model selections. This week two of four picks gained over 10% in less than a week with peak gains in CLLS +16.8% AUTL+15.5% but the portfolio failed to hold gains. The streak of weekly picks gaining over 10% in less than a week has increased to 255 out of 322 trading weeks (79.2%) not including multiple gainers or warning signals.

August MDA Breakout Stocks Week 31 - 2023: High-Frequency Gainers To Give You An Edge

NEW YORK--(BUSINESS WIRE)--DocGo Inc (Nasdaq: DCGO), a leading provider of last-mile mobile health services, announced today that Anthony Capone, Chief Executive Officer will participate in a fireside chat at the Canaccord Genuity 43rd Annual Growth Conference on Wednesday, August 9 at 8:30 AM Eastern Time. A webcast of the event will be available on the investor relations section of DocGo's website at https://ir.docgo.com/. About DocGo DocGo is leading the proactive healthcare revolution with.

DocGo Announces Upcoming Participation at Canaccord Genuity 43rd Annual Growth Conference

NEW YORK--(BUSINESS WIRE)--DocGo Inc., a leading provider of last-mile mobile health services (Nasdaq: DCGO), today announced that the company will report results for the second quarter ended June 30, 2023, after the markets close on Monday, August 7th. Management will host a conference call for analysts and investors at 5:00pm ET on that day. Conference call and webcast details: Monday, August 7th, 5:00pm EDT 1-877-407-0784 (U.S.) 1-201-689-8560 (international) Conference ID: 13739932 To acces.

DocGo to Announce Second Quarter 2023 Results on Monday, August 7th

NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq:DCGO), a leading provider of last-mile mobile health services, is pleased to announce the expansion of its partnership with HealthCare Partners NY, an organization led by physicians that empowers healthcare providers to deliver exceptional healthcare to patients in New York. This strategic partnership marks a significant milestone in DocGo's mission to offer accessible, high-quality healthcare to all individuals. Building on the success of a pilot p.

DocGo and HealthCare Partners NY Expand Partnership to Enhance Proactive At-Home Care for Patients

DocGo Inc. (DCGO) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

DocGo Inc. (DCGO) Surges 5.0%: Is This an Indication of Further Gains?

NEW YORK--(BUSINESS WIRE)--DocGo Inc (Nasdaq: DCGO), a leading provider of last-mile mobile health services, will be hosting an in-person Investor Day on Tuesday, June 20th, 2023 from 12:30–3:00 pm ET at the Nasdaq MarketSite in New York. DocGo's model is changing the future of healthcare delivery by bringing proactive mobile care to more people while lowering costs and improving outcomes. The event will include presentations from DocGo's executive leadership team, and will feature the followin.

Reminder - DocGo to Host In-Person Investor Day on Tuesday June 20, 2023

DocGo is well-positioned to capture a significant share of the under-penetrated $250 billion virtual healthcare market. The company's user-friendly platform and real-time data access provide a competitive advantage, supporting long-term growth prospects. I view the stock as a buy, with an end of year price target of $13 on the stock.

DocGo: Poised For Success In The Lucrative Virtual Healthcare Market

NEW YORK--(BUSINESS WIRE)--DocGo Inc (Nasdaq: DCGO), a leading provider of last-mile mobile health services, announced today that Anthony Capone, Chief Executive Officer will participate in a fireside chat at the Stifel 2023 Cross Sector Insight Conference on Wednesday, June 7 at 11:30 AM Eastern Time. A webcast of the event will be available on the investor relations section of DocGo's website at https://ir.docgo.com/. About DocGo DocGo is a leading provider of last-mile mobile care services.

DocGo Announces Upcoming Participation at Stifel 2023 Cross Sector Insight Conference

DocGo delivered what analysts at Canaccord called “mixed” results, but that was enough for the firm to reiterate its Buy rating and $13 price target.  “At first glance, DocGo's 1Q results can be seen as mixed,” analysts wrote.

DocGo's growth story keeps building, analysts say after mixed 1Q results

DocGo, Inc. (DGCO) Q1 2023 Earnings Conference Call May 8, 2023 5:00 PM ET Company Participants Mike Cole – Director-Investor Relations Anthony Capone – Chief Executive Officer Lee Bienstock – President and Chief Operating Officer Norm Rosenberg – Chief Financial Officer Conference Call Participants Mike Latimore – Northland Capital Markets Matt Shea – Needham John Pinney – Canaccord Genuity Craig Jones – Stifel Sarah James – Cantor Fitzgerald Jeb Terry – Aberdeen Investment Management Operator Greetings, and welcome to the DocGo First Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode.

DocGo, Inc. (DCGO) Q1 2023 Earnings Call Transcript

DocGo Inc. (DCGO) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of $0.03. This compares to earnings of $0.09 per share a year ago.

DocGo Inc. (DCGO) Reports Q1 Loss, Lags Revenue Estimates

NEW YORK--(BUSINESS WIRE)--DocGo Reiterates 2023 Revenue Guidance of $500-$510 million and Adjusted EBITDA Guidance of $45-$50 million in first quarter 2023 results.

DocGo Announces First Quarter 2023 Results

NEW YORK--(BUSINESS WIRE)--DocGo Inc (Nasdaq: DCGO), a leading provider of last-mile mobile health services, announced today that Anthony Capone, Chief Executive Officer will participate in a fireside chat at the 18th Annual Needham Technology and Media Conference on Tuesday, May 16 at 9:30 AM Eastern Time. A webcast of the event will be available on the investor relations section of DocGo's website at https://ir.docgo.com/. About DocGo DocGo is a leading provider of last-mile mobile care servi.

DocGo Announces Upcoming Participation at 18th Annual Needham Technology and Media Conference

NEW YORK--(BUSINESS WIRE)--DocGo, a leading provider of last-mile mobile health services (Nasdaq: DCGO), and New York City Health + Hospitals today announced that they are the recipient of the “Best Overall Mobile Health Solution” award for their partnership in the Street Health Outreach + Wellness (SHOW) program, in the 7th annual MedTech Breakthrough Awards program conducted by MedTech Breakthrough. MedTech Breakthrough is an independent market intelligence organization that recognizes the to.

New York City Health + Hospitals and DocGo Recognized for Mobile Health Innovation in 7th Annual MedTech Breakthrough Awards Program

NEW YORK--(BUSINESS WIRE)--DocGo will host an in-person Investor Day on Tuesday, June 20th, 2023 from 12:30–3:00 pm ET at the Nasdaq MarketSite in New York.

DocGo to Host In-Person Investor Day at Nasdaq MarketSite in New York on June 20

NEW YORK--(BUSINESS WIRE)--DocGo (Nasdaq:DCGO), a leading provider of last-mile mobile health services, today announced it has entered into a preferred provider agreement with Fresenius Medical Care (FMC) – the largest provider of kidney dialysis treatment in the United States. This preferred provider agreement includes remote patient monitoring, principal care management, chronic care management, and urgent care services. DocGo has been an FMC preferred medical transportation partner since 201.

DocGo Announces Strategic Mobile Health Agreement with Fresenius Medical Care

NEW YORK--(BUSINESS WIRE)--DocGo will announce Q1 2023 results on Monday, May 8th, via conference call.

DocGo to Announce First Quarter 2023 Results on Monday, May 8th

NEW YORK--(BUSINESS WIRE)--DocGo Inc (Nasdaq: DCGO), a leading provider of last-mile mobile health services, announced today that Lee Bienstock, President and Chief Operating Officer will participate in a fireside chat at the 22nd Annual Needham Virtual Healthcare Conference on Thursday, April 20 at 2:15PM Eastern Time. A webcast of the event will be available on the investor relations section of DocGo's website at https://ir.docgo.com/.

DocGo Announces Upcoming Participation at 22nd Annual Needham Virtual Healthcare Conference

NEW YORK--(BUSINESS WIRE)--DocGo CEO Anthony Capone will present at the HIMSS 2023 conference alongside Kent Dicks of Life365 and John Bennett of Microsoft Corporation.

DocGo's Anthony Capone to Present on Virtual First Medical Care Delivery at HIMSS 2023 Conference

Newmont Mining

NVIDIA

Franco-Nevada Corporation (TSX:FNV) reported its fourth quarter and year-end 2022 operating and financial results on Wednesday, with the gold-focused royalty and streaming company providing softer-than-expected 2023 guidance of 640,000 to 700,000 gold equivalent ounces (GEOs) sold, Stifel GMP analysts wrote in a report published on Thursday.

Analyst calls of the week: NVIDIA, DocGo, TerrAscend, Newmont Gold and more

We saw our previous prediction of municipal contracts helping cushion DocGo's revenue (absent of the Covid test) work out for its full year of 2022. The technological advantage in operations and low debt burden combined with ample liquidity put the company on a strong footing for future growth.

News for DocGo Stock (DCGO)